Akathisia induced by concurrent use of mirogabalin and sulfamethoxazole-trimethoprim: a case report
Abstract Background Mirogabalin and trimethoprim-sulfamethoxazole (TMP/SMX) are frequently used as supportive purpose during and/or after chemotherapy. Mirogabalin is used to treat neuropathic pain, whereas TMP/SMX is used to prevent pneumocystis pneumonia (PCP) in patients who are immunocompromised...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2026-04-01
|
| Serier: | Journal of Pharmaceutical Health Care and Sciences |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s40780-026-00578-y |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
